128 related articles for article (PubMed ID: 6245621)
1. Herpes zoster-varicella in cutaneous T-cell lymphomas.
Vonderheid EC; van Voorst Vader PC
Arch Dermatol; 1980 Apr; 116(4):408-12. PubMed ID: 6245621
[TBL] [Abstract][Full Text] [Related]
2. Chronic herpes simplex infection in cutaneous T-cell lymphomas.
Vonderheid EC; Milstein HJ; Thompson KD; Wu BC
Arch Dermatol; 1980 Sep; 116(9):1018-22. PubMed ID: 6968178
[TBL] [Abstract][Full Text] [Related]
3. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma.
Cook BE; Bartley GB; Pittelkow MR
Ophthalmology; 1999 Jul; 106(7):1339-44. PubMed ID: 10406618
[TBL] [Abstract][Full Text] [Related]
6. Mycosis fungoides and the Sézary syndrome.
Kim YH; Hoppe RT
Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
[TBL] [Abstract][Full Text] [Related]
7. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
Bouwhuis SA; Davis MD; el-Azhary RA; McEvoy MT; Gibson LE; Knudsen JM; Kist JM; Pittelkow MR
J Am Acad Dermatol; 2005 Jun; 52(6):991-6. PubMed ID: 15928617
[TBL] [Abstract][Full Text] [Related]
8. Skeletal manifestations in cutaneous T-cell lymphomas.
Brigham BA; Bunn PA; Horton JE; Schechter GP; Wahl LM; Bradley EC; Dunnick NR; Matthews MJ
Arch Dermatol; 1982 Jul; 118(7):461-7. PubMed ID: 6979976
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
Whittaker SJ; Foss FM
Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
[TBL] [Abstract][Full Text] [Related]
10. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
11. Infections complicating mycosis fungoides and Sézary syndrome.
Axelrod PI; Lorber B; Vonderheid EC
JAMA; 1992 Mar; 267(10):1354-8. PubMed ID: 1740857
[TBL] [Abstract][Full Text] [Related]
12. Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas.
Bunn PA; Fischmann AB; Schechter GP; Kumar PP; Ihde DC; Cohen MH; Fossieck BE; Gazdar AF; Matthews MJ; Eddy JL; Minna JD
Cancer Treat Rep; 1979 Apr; 63(4):713-7. PubMed ID: 109208
[No Abstract] [Full Text] [Related]
13. Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage.
Kerschmann RL; Berger TG; Weiss LM; Herndier BG; Abrahms KM; Heon V; Schulze K; Kaplan LD; Resnik SD; LeBoit PE
Arch Dermatol; 1995 Nov; 131(11):1281-8. PubMed ID: 7503572
[TBL] [Abstract][Full Text] [Related]
14. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic pityriasis lichenoides in cutaneous lymphoma: case report and review of the literature on paraneoplastic reactions of the skin in lymphoma and leukaemia.
Kempf W; Kutzner H; Kettelhack N; Palmedo G; Burg G
Br J Dermatol; 2005 Jun; 152(6):1327-31. PubMed ID: 15949002
[TBL] [Abstract][Full Text] [Related]
16. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of cutaneous T-cell lymphomas with arotinoid].
Mahrle G; Thiele B; Ippen H
Dtsch Med Wochenschr; 1983 Nov; 108(46):1753-7. PubMed ID: 6605844
[TBL] [Abstract][Full Text] [Related]
18. Disseminated cutaneous herpes simplex infection in cutaneous T-cell lymphoma.
Taulbee KS; Johnson SC
Arch Dermatol; 1981 Feb; 117(2):114-5. PubMed ID: 6970545
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma.
Cook BE; Bartley GB; Pittelkow MR
Trans Am Ophthalmol Soc; 1998; 96():309-24; discussion 324-7. PubMed ID: 10360295
[TBL] [Abstract][Full Text] [Related]
20. Mycosis fungoides: pathophysiology and emerging therapies.
Duvic M; Foss FM
Semin Oncol; 2007 Dec; 34(6 Suppl 5):S21-8. PubMed ID: 18086343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
